BioSpace News Archive

Youngevity International, Inc. (NASDAQ:YGYI), a leading multi-channel lifestyle company, today announced the launch of its Hemp FX, phytocannabinoid-rich hemp oil product line, in Japan

Key national experts announce a new unique consulting partnership focusing on due diligence for private equity firms combining deep local analysis with national policy review on regulation and payment.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will highlight its enabling technologies at the North American Spine Society (NASS) Annual Meeting, September 25-28, 2019 at McCormick Place in Chicago.

Deep Genomics, the leading AI therapeutics company, announced today that its proprietary artificial intelligence-based drug discovery platform has identified a novel treatment target and corresponding drug candidate for Wilson disease, a rare, serious, and potentially life-threatening genetic disorder.

Company Plans to Complete Financing in First Quarter of 2020

The award is through the Broad Agency Announcement (BAA) program to advance Versatope’s universal influenza vaccine candidate.

CB Therapeutics is a leading synthetic biotechnology company focused on the research and development of cellular agriculture for the production of high-value molecules, compounds and rare ingredients.

Plan to Submit Applications for Multiple Spine Devices to FDA in 2019

Wolfenson along with Lonza, a Leading Healthcare Company, Teamed Up to Promote the Advantages of UC-II® (Undenatured Type II Collagen) for Healthy Joints and Bodies in Motion

RxCrossroads by McKesson and CoverMyMeds today announced the launch of AMP: Access for More PatientsTM, a first-in-class, technology-driven patient support solution that transforms how patients access, afford and adhere to their medications.